Pharmanest (Sweden)

Recent papers from Pharmanest (Sweden)

1. Fibrotic remodeling in the NOD/ShiLtJ mouse model of Sjögren’s disease: insights from single-cell transcriptomics and AI-driven ECM quantificationFrontiers in Immunology · 2026
2. AI-assisted, single-fiber digital pathology quantification of changes in liver fibrosis after bariatric surgeryHepatology Communications · 2026
3. Anti-FAP CAR T cells produced in vivo reduce fibrosis and restore liver homeostasis in metabolic dysfunction-associated steatohepatitis.2026
4. Scar-associated endothelial-stellate cellular crosstalk drives fibrosis resolution in MASH2025
5. Structural basis of ZP2-targeted immunocontraception2025
6. In vivo anti-FAP CAR T therapy reduces fibrosis and restores liver homeostasis in metabolic dysfunction-associated steatohepatitis2025
7. Wcn24-1252 Quantitative Image Analysis Reveals Podocytes Effacement and Kidney Fibrosis in SDT Fatty Rats With Impaired Renal Function by Unilateral Nephrectomy and Salt Supplemented DietKidney International Reports · 2024
8. Mannose Supplementation Curbs Liver Steatosis and Fibrosis in Murine MASH by Inhibiting Fructose Metabolism2024
9. ILSI/HESI maternal toxicity workshop summary: maternal toxicity and its impact on study design and data interpretationBirth Defects Research Part B Developmental and Reproductive Toxicology · 2010